Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

被引：1301
|
作者：
Kebir, Hania
Kreymborg, Katharina
Ifergan, Igal
Dodelet-Devillers, Aurore
Cayrol, Romain
Bernard, Monique
Giuliani, Fabrizio
Arbour, Nathalie
Becher, Burkhard
Prat, Alexandre
机构：
[1] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Ctr Study Brain Dis,Neuroimmunol Unit, Montreal, PQ H2L 4M1, Canada
[2] Univ Zurich, Dept Neurol, Div Neuroimmunol, CH-8057 Zurich, Switzerland
[3] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB T6G 2G3, Canada
来源：
NATURE MEDICINE | 2007年 / 13卷 / 10期
基金：
加拿大健康研究院;
关键词：
D O I：
10.1038/nm1651
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL- 17 and IL- 22 receptors on blood- brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL- 17 and IL- 22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4(+) lymphocyte recruitment.
引用
收藏
页码：1173 / 1175
页数：3
相关论文
共 50 条
  • [41] The blood-brain barrier and its role in immune privilege in the central nervous system
    Pachter, JS
    de Vries, HE
    Fabry, Z
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (06): : 593 - 604
  • [42] Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
    Rice, Olivia
    Surian, Allison
    Chen, Yupeng
    JOURNAL OF TISSUE ENGINEERING, 2022, 13
  • [43] Regulation of the Blood-Brain Barrier: New Treatments for Central Nervous System Neoplasms
    Kalra, Ricky
    Couldwell, William T.
    WORLD NEUROSURGERY, 2011, 75 (02) : 179 - 180
  • [44] The blood-brain barrier: Principles for targeting peptides and drugs to the central nervous system
    Begley, DJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (02) : 136 - 146
  • [45] BLOOD-BRAIN BARRIER AND GROUND SUBSTANCE OF CENTRAL NERVOUS SYSTEM - SIMILARITIES IN DEVELOPMENT
    HESS, A
    ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1955, 73 (APR): : 380 - 386
  • [46] Glucocorticoid signalling and resistance at the blood-brain barrier in central nervous system disorders
    Kleinschnitz, Christoph
    Blecharz, Kinga
    Kahles, Timo
    Schwarz, Tobias
    Kraft, Peter
    Goebel, Kerstin
    Meuth, Sven G.
    Burek, Malgorzata
    Tha, Serge
    Scheffer, David
    Thum, Thomas
    Stoll, Guido
    Foerster, Carola
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 355 - 355
  • [47] The impacts of tobacco and nicotine on HIV-1 infection, inflammation, and the blood-brain barrier in the central nervous system
    Keane, Aislinn M.
    Swartz, Talia H.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] DIFFERENCES IN EFFECTIVITY OF THE BLOOD-BRAIN BARRIER IN DIFFERENT PARTS OF CENTRAL NERVOUS SYSTEM
    Brattgard, Sven-Olof
    Lindqvist, Torsten
    ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA, 1955, 30 (03): : 423 - 436
  • [49] ABSENCE OF BLOOD-BRAIN BARRIER FROM CERTAIN AREAS OF CENTRAL NERVOUS SYSTEM
    WILSON, CW
    BRODIE, BB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1961, 133 (03): : 332 - &
  • [50] Proepileptogenic effects of human blood-brain barrier disruption
    Marchi, N.
    Angelov, L.
    Masaryk, T.
    Fazio, V.
    Janigro, D.
    EPILEPSIA, 2006, 47 : 148 - 149
12345